Effect of sodium diphenylhydantoin on skin wound healing in rats

Plastic and Reconstructive Surgery

Volumn 112, Issue 6, 2003, Pages 1620-1627

  Habibipour, Saeid ^a,b   Oswald, Tanya M ^a,b   Zhang, Feng ^a,b   Joshi, Pratibha ^a,b   Zhou, Xin Chun ^a,b   Dorsett Martin, Wanda ^a,b   Lineaweaver, William C ^a,b  

^a Univ of Mississippi Medical Center ^*

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHENYTOIN; ACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; FULL THICKNESS SKIN GRAFT; GENE EXPRESSION; HISTOPATHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; SAMPLING; SKIN INJURY; SKIN ULCER; TENSILE STRENGTH; WOUND CONTRACTION; WOUND HEALING; ANIMAL; FIBROBLAST; GENETICS; IN VITRO STUDY; INJURY; METABOLISM; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; SPRAGUE DAWLEY RAT;

ACTINS; ANIMALS; CHEMOKINE CCL2; CHEMOKINES; FIBROBLASTS; GENE EXPRESSION; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; PHENYTOIN; RATS; RATS, SPRAGUE-DAWLEY; SKIN; TENSILE STRENGTH; WOUND HEALING;

EID: 0642282223     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000086773.96319.DA     Document Type: Article

References (43)

1. Merritt, H.H., and Putnam, T.J. Landmark article September 17, 1938: Sodium diphenylhydantoinate in the treatment of convulsive disorders. J.A.M.A. 251: 1062, 1984.
2. Kimball, O. P., and Horan, T. N. The use of dilantin in the treatment of epilepsy. Ann. Intern. Med. 13: 787, 1939.
3. Shapiro, M. Acceleration of gingival wound healing in non-epileptic patients receiving diphenylhydantoin. Exp. Med. Surg. 16: 41, 1958.
4. El Zayat, S. G. Preliminary experience with topical phenytoin in wound healing in a war zone. Mil. Med. 154: 178, 1989.
5. Muthukumarasamy, M. G., Sivakumar, G., and Manoharan, G. Topical phenytoin in diabetic foot ulcers. Diabetes Care 14: 909, 1991.
6. Anstead, G. M., Hart, L. M., Sunahara, J. F., and Liter, M. E. Phenytoin in wound healing. Ann. Pharmacother. 30: 768, 1996.
7. Mendiola-Gonzalez, J. F., Espejo-Plascencia, I., Chapa-Alvarez, J. R., et al. Sodium diphenylhydantoin in burns: Effects on pain and healing. Invest. Med. Int. 10: 443, 1983.
8. Lodha, S. C. New application of an old drug: Topical phenytoin for burns (Letter). J. Burn Care Rehabil. 12: 96, 1991.
9. Savini, E. C., Poltevin, R., and Poltevin, J. New treatment of periodontolysis. Rev. Odontol. Stomatol. 19: 55, 1972.
10. Payen, J. A study of changes in the gum during treatment with diphenylhydantoin sodium. Rev. Odontol. Stomatol. 19: 47, 1972.
11. Modaghegh, S., Salehian, B., Tavassoli, M., Djamshidi, A., and Rezai, A. S. Use of phenytoin in the healing of war and non-war wounds: A pilot study of 25 cases. Int. J. Dermatol. 28: 373, 1986.
12. Bogaert, H., Saleta, B., and Sanchez, E. Trophic leprosy ulcers: Treatment with topical and systemic phenytoin (Letter). Int. J. Dermatol. 29: 156, 1990.
13. Molhotra, Y. K., and Amin, S. S. Role of phenytoin in trophic ulcers of leprosy in India (Letter). Int. J. Lepr. 59: 337, 1991.
14. Bodkin, L. G. Oral therapy for pruritus ani. Am. J. Dig. Dis. 12: 255, 1945.
15. Bansal, N. K., and Mukul, N. Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. Int. J. Dermatol. 32: 210, 1993.
16. Pollack, S. V. Wound healing: A review. IV. Systemic mediation affecting wound healing. J. Dermatol. Surg. Oncol. 8: 667, 1982.
17. Finkle, J. M. Phenytoin revisited. Clin. Ther. 6: 577, 1984.
18. Shafer, W. G. Effect of dilantin sodium on various cell lines in tissue cultures. Proc. Soc. Exp. Biol. Med. 108: 694, 1961.
19. Houck, J. C., Cheng, R. F., and Waters, M. D. Diphenylhydantoin: Effects on connective tissue and wound repair. In D. M. Woodbury, J. K. Penry, and P. R. Schmidt (Eds.), Antiepileptic Drugs. New York: Raven Press, 1972. P. 267.
20. Vijayasingham, S. M., Dykes, P. J., and Marks, R. Phenytoin has little effect on in-vitro models of wound healing. Br. J. Dermatol. 125: 136, 1991.
21. Hassell, T. M., and Gilbert, G. H. Phenytoin sensitivity of fibroblasts as the basis for susceptibility to gingival enlargement. Am. J. Pathol. 112: 218, 1983.
22. Moy, L. S., Tan, E. M. L., Holness, R., and Uitto, J. Phenytoin modulates connective tissue metabolism and cell proliferation in human skin fibroblast cultures. Arch. Dermatol. 121: 79, 1985.
23. Kasai, S., and Hachimine, K. Effect of 5, 5-diphenylhydantoin sodium on the synthesis of collagen by some fibroblastic cell lines including gingiva derived cells. Bull. Tokyo Dent. Coll. 15: 53, 1974.
24. Narayanan, A. S., Meyers, D. F., and Page, R. C. Regulation of collagen production in fibroblasts cultured from normal and phenytoin-induced hyperplastic human gingiva. J. Periodont. Res. 23: 118, 1988.
25. Bazin, S., and Delaunay, A. Effect of phenytoin on the maturation of collagen in normal skin and granulomatous tissue. C. R. Acad. Sci. Paris, Series D 275: 509, 1972.
26. Eisenberg, M., Stevens, L. H., and Schofield, P. J. Epidermolysis bullosa: New therapeutic approaches. Aust. J. Dermatol. 9: 1, 1978.
27. Bauer, E. A., Cooper, T. W., Tucker, D. R., and Esterly, N. B. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. N. Engl. J. Med. 303: 776, 1980.
28. Lodha, S. C., Lohiya, M. L., Vyas, M. C., Bhandari, S., Goyal, R. R., and Harsh, M. K. Role of phenytoin in healing of large abscess cavities. Br. J. Surg. 78: 105, 1991.
29. Pendse, A. K., Sharma, A., Sodani, A., and Hada, S. Topical phenytoin in wound healing. Int. J. Dermatol. 32: 214, 1993.
30. Frank, C., McDonald, D., Bray, D., et al. Collagen fibril diameters in the healing adult rabbit medial collateral ligament. Connect. Tissue Res. 27: 251, 1992.
31. Frank, C., McDonald, D., Wilson, J., Eyre, D., and Shrive, N. Rabbit medial collateral ligament scar weakness is associated with decreased collagen pyridinoline crosslink density. J. Orthop. Res. 13: 157, 1995.
32. DaCosta, M. L., Regan, M. C., Al Sader, M., Leader, M., and Bouchier-Hayes, D. Diphenylhydantoin sodium promotes early and marked angiogenesis and results in increased collagen deposition and tensile strength in healing wounds. Surgery 123: 287, 1998.
33. Fink, M. P. The role of cytokines as mediators of the inflammatory response. In: C. M. Townsend, Jr., R. D. Beauchamp, B, M. Evers, and K, L. Mattox (Eds.), Sabiston Textbook of Surgery. Philadelphia: Saunders, 2001. P. 28.
34. Rodriquez-Ramos, C., Galan, F., Diaz, F., Elvira, J., Martin-Herra, L., and Giron-Gonzalez, J. A. Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis. Dig. Dis. Sci. 46: 1668, 2001.
35. Koniaris, L. G., Zimmers-Koniaris, T., Hsiao, E. C., Chavin, K., Sitzmann, J. V., and Farber, J. M. Cytokine-responsive gene-2/IFN-inducible protien-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J. Immunol. 167: 399, 2001.
36. Wetzler, C., Kampfer, H., Stallmeyer, B., Pfeilschifter J., and Frank, S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: Prolonged persistence of neutrophils and macrophages during the late phase of repair. J. Invest. Dermatol. 115: 245, 2000.
37. Martins-Green, M., and Feugate, J. E. The 9E3/CEF4 gene product is a chemotactic and angiogenic factor that can initiate the wound-healing cascade in vivo. Cytokine 10: 522, 1998.
38. Weber, K. S., Nelson, P. J., Grone, H. F., and Weber, C. Expression of CCR2 by endothelial cells: Implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arter. Thromb. Vasc. Biol. 19: 2085, 1999.
39. Jackman, S. H., Yoak, M. B., Keerthy, S., and Beaver, B. L. Differential expression of chemokines in a mouse model of wound healing. Ann. Clin. Lab. Sci. 30: 201, 2000.
40. Nirodi, C. S., Devalaraja, R., Nanney, L. B., et al. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen. 8: 371, 2000.
41. Gillitzer, R., and Goebeler, M. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69: 513, 2001.
42. Humphries, J., McGuinness, C. L., Smith, A., Waltham, M., Poston, R., and Burnand, K. G. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J. Vasc. Surg. 30: 894, 1999.
43. Dipietro, L. A., Reintjes, M. G., Low, Q. E., Levi, B., and Gamelli, R. L. Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1. Wound Repair Regen. 9: 28, 2001.